News-Leader Staff

The state of Missouri will receive more than $3.1 million as part of a multistate $465 million settlement against Mylan Inc., Attorney General Josh Hawley announced Thursday in a news release.

This settlement resolves allegations that Mylan knowingly underpaid rebates owed to Missouri’s Medicaid program for the sales of EpiPen and EpiPen Jr.

The case alleged that from July 29, 2010 to March 31, 2017, Mylan submitted false statements to the Centers for Medicare and Medicaid Services that incorrectly classified EpiPen as a “non-innovator multiple source” drug, as opposed to a “single source” or “innovator multiple source” drug, as those terms are defined in the Rebate Statute and Rebate Agreement. Mylan also did not report a Best Price to CMS for EpiPen, which it was required to do for all “single source” and “innovator multiple source” drugs, the release said. As a result, Mylan submitted or caused to be submitted false statements to CMS relating to EpiPen for Medicaid rebate purposes and underpaid its EpiPen rebates to state Medicaid programs, including Missouri.

“There is no place for Medicaid Fraud in Missouri,” Hawley said in the release. “We will not tolerate the misuse of taxpayer money. I am grateful to the agencies that worked on this case and I am pleased that this money will be returned.”

Reporting suspected Medicaid fraud

Hawley encourages individuals to report suspected Medicaid fraud to his office. State law provides that a whistleblower may be entitled to 10 percent of any Medicaid fraud money recovered in a civil suit as a result of their tip. Missourians can report suspected Medicaid provider fraud and abuse through the Attorney General’s Medicaid Fraud Hotline at 800-286-3932 or online at http://ago.mo.gov/divisions/medicaid-provider-fraud.